Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Novel focal ablation system proceeds through prostate cancer pipeline

A streamline procedure allows treatment with the NanoTherm therapy system for focal ablation to be completed within 1 day.

Patient treatment has been completed in the initial part of stage 2 of a pivotal trial of the NanoTherm therapy system for the focal ablation of intermediate-risk prostate cancer, according to MagForce AG, the developer of the therapy.1

Read the full article here. 

source: Josh M. Broderick - Urology Times